Should you fade Jim Cramer… or follow him? That’s the eternal Lightning Round question. And this week, with Marvell (MRVL) getting Cramer’s stamp of approval while Bausch Health (BHC) quietly grinds through another turnaround quarter, traders have a real fork in the road. Here’s the call: Follow Cramer on Marvell. Fade the complacency on Bausch.…